13F
← All fund report cards

ZACKS INVESTMENT MANAGEMENT

13F equity value
$12.5B
Positions
706
Top 10 concentration
26.6%
Quarters / total new picks
32 / 2,366
13F equity value over time
$0M$6B$13B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.5% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 1.38, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.2%
t-stat
1.38
Quarterly win rate
56%
Annualized excess
+3.0%
$1 → follow vs universe
$2.60 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.06320180630: follow 0.96720180930: follow 1.04120181231: follow 1.04020190331: follow 1.06920190630: follow 1.13120190930: follow 1.18220191231: follow 0.92420200331: follow 1.11520200630: follow 1.20120200930: follow 1.44720201231: follow 1.53920210331: follow 1.67020210630: follow 1.83620210930: follow 1.60020211231: follow 1.43220220331: follow 1.51720220630: follow 1.42420220930: follow 1.48920221231: follow 1.35320230331: follow 1.40220230630: follow 1.38520230930: follow 1.60720231231: follow 1.77920240331: follow 1.83520240630: follow 2.04420240930: follow 2.00020241231: follow 1.88720250331: follow 2.03920250630: follow 2.08220250930: follow 2.35720251231: follow 2.596 0.84 1.82 2.80 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 706 · 2026 Q1

Ticker Value Weight QoQ
NVDA $489M
3.9%
HOLD
AAPL $437M
3.5%
ADD
GOOGL $429M
3.4%
HOLD
MSFT $409M
3.3%
ADD
CAT $296M
2.4%
HOLD
JPM $269M
2.1%
TRIM
WMT $260M
2.1%
HOLD
XOM $255M
2.1%
HOLD
AVGO $242M
1.9%
HOLD
META $238M
1.9%
TRIM
AMZN $238M
1.9%
ADD
JNJ $214M
1.7%
HOLD
PH $184M
1.5%
HOLD
CSCO $181M
1.5%
HOLD
ABBV $177M
1.4%
ADD
PG $170M
1.4%
HOLD
HD $167M
1.3%
HOLD
COP $164M
1.3%
ADD
BLK $133M
1.1%
HOLD
PM $133M
1.1%
HOLD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.